tiprankstipranks
Advertisement
Advertisement

BSEM Stock Latest News

BioStem’s BR-AM Trial Completion Sets the Stage for Next Moves in Diabetic Wound Care
Company AnnouncementsBioStem’s BR-AM Trial Completion Sets the Stage for Next Moves in Diabetic Wound Care
5d ago
BSEM
BSEM Earnings this Week: How Will it Perform?
PremiumPre-Earnings
BSEM Earnings this Week: How Will it Perform?
8d ago
BSEM
BioStem Technologies Uplists to Nasdaq Capital Market
PremiumCompany Announcements
BioStem Technologies Uplists to Nasdaq Capital Market
10d ago
8K
BSEM
BioStem files registration statement with SEC, to pursue Nasdaq listing
PremiumThe Fly
BioStem files registration statement with SEC, to pursue Nasdaq listing
1M ago
BSEM
BioStem Technologies issued four U.S. design patents for allograft technology
PremiumThe Fly
BioStem Technologies issued four U.S. design patents for allograft technology
1M ago
BSEM
BioStem Technologies announces notice of allowance for four patents
PremiumThe FlyBioStem Technologies announces notice of allowance for four patents
3M ago
BSEM
BioStem Technologies price target lowered to $7 from $9 at H.C. Wainwright
Premium
The Fly
BioStem Technologies price target lowered to $7 from $9 at H.C. Wainwright
3M ago
BSEM
BioStem Technologies (BSEM) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
BioStem Technologies (BSEM) Q1 Earnings Cheat Sheet
3M ago
BSEM
Biostem Technologies initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Biostem Technologies initiated with a Buy at H.C. Wainwright
3M ago
BSEM
BioStem Technologies Balances Bold Acquisition With Strain
PremiumCompany Announcements
BioStem Technologies Balances Bold Acquisition With Strain
5M ago
BSEM
BSEM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
BSEM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
BSEM
BioStem’s Diabetic Foot Ulcer Trial Reaches Completion: What Investors Should Watch Next
PremiumCompany Announcements
BioStem’s Diabetic Foot Ulcer Trial Reaches Completion: What Investors Should Watch Next
7M ago
BSEM
BioStem Technologies Q3 Earnings Call Highlights Resilience
PremiumCompany AnnouncementsBioStem Technologies Q3 Earnings Call Highlights Resilience
9M ago
BSEM
BioStem Technologies Reports Q3 2025 Financial Results
Premium
Company Announcements
BioStem Technologies Reports Q3 2025 Financial Results
9M ago
BSEM
BSEM Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
BSEM Upcoming Earnings Report: What to Expect?
9M ago
BSEM
BioStem Technologies’ Promising Clinical Trial for Venous Leg Ulcers: A Potential Game-Changer
PremiumCompany Announcements
BioStem Technologies’ Promising Clinical Trial for Venous Leg Ulcers: A Potential Game-Changer
10M ago
BSEM
BioStem Technologies’ Promising Study on Diabetic Foot Ulcers: A Potential Game-Changer
PremiumCompany Announcements
BioStem Technologies’ Promising Study on Diabetic Foot Ulcers: A Potential Game-Changer
10M ago
BSEM
BioStem Technologies’ Earnings Call: Mixed Sentiment Amid Growth Plans
PremiumCompany Announcements
BioStem Technologies’ Earnings Call: Mixed Sentiment Amid Growth Plans
12M ago
BSEM
BioStem Technologies Reports Q2 2025 Financial Results
PremiumCompany Announcements
BioStem Technologies Reports Q2 2025 Financial Results
1y ago
BSEM
BioStem Technologies’ Innovative Approach to Healing Venous Leg Ulcers: A Clinical Study Update
PremiumCompany AnnouncementsBioStem Technologies’ Innovative Approach to Healing Venous Leg Ulcers: A Clinical Study Update
1y ago
BSEM
BioStem’s BR-AM Trial: A Potential Game-Changer for Diabetic Foot Ulcers
Premium
Company Announcements
BioStem’s BR-AM Trial: A Potential Game-Changer for Diabetic Foot Ulcers
1y ago
BSEM
BioStem Technologies Advances Diabetic Foot Ulcer Treatment with BR-AM Study
Premium
Company Announcements
BioStem Technologies Advances Diabetic Foot Ulcer Treatment with BR-AM Study
1y ago
BSEM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >